Abstract
Scleroderma and ANCA-associated vasculitides (AAV), such as microscopic polyangiitis, are distinct disease entities, but are rarely known to coexist with each other. We have reported on two cases of scleroderma patients for the first time in Korea, and these patients were initially known to have only limited type scleroderma with pulmonary fibrosis, but eventually they were found to be ANCA-positive with the associated clinical features of vasculitis. Both were treated with high-dose steroids and cyclophosphamide and remitted without major sequelae. When scleroderma patients exhibit atypical features such as normotensive renal failure with signs of active inflammation, the possibility of AAV should always be considered.
This is a preview of subscription content, log in via an institution to check access.
References
Endo H, Hosono T, Kondo H (1994) Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21:864–870
Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113:352–357
Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619
Donohoe JF (1992) Scleroderma and the kidney. Kidney Int 41:462–477
Katrib A, Sturgess A, Bertouch JV (1999) Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 19:61–63
Casari S, Haeney M, Farrand S, Herrick A (2002) Antineutrophil cytoplasmic antibodies a “Red Flag” in patients with systemic sclerosis. J Rheumatol 29:2666–2667
Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R, Tanaka H et al (1997) Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies – related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 36:508–513
Homma S, Matsushita H, Nakata K (2004) Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 9:190–196
Lhote F, Cohen P, Genereau T, Gayraud M, Guillevin L (1996) Microscopic polyangiitis: clinical aspects and treatment. Ann Med Interne (Paris) 147:165–177
Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104:7–16
Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE (1990) Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 65:847–856
Eschun GM, Mink SN, Sharma S (2003) Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 123:297–301
Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M et al (2002) Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 29:918–923
Kiraz S, Simsek H, Ertenli I, Benekli M, Kadayifci A (1996) Antineutrophil cytoplasmic antibodies in systemic sclerosis. Clin Rheumatol 15:519–520
Caramaschi P, Biasi D, Tonolli E, Carletto A, Bambara LM (2002) Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature. Joint Bone Spine 69:177–180
Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R (2003) Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30:1248–1252
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rho, Y.H., Choi, S.J., Lee, Y.H. et al. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 26, 465–468 (2006). https://doi.org/10.1007/s00296-005-0003-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-005-0003-5